Dear Sir, Please find Report on action taken under the Special Window for re-lodgement of transfer request from 01.01.2026 to 06.01.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has submitted a routine compliance report to BSE regarding the SEBI Special Window for re-lodgement of physical share transfer requests, covering the period 1 January to 6 January 2026. The report was filed by Alankit Assignments Limited, the company's Registrar and Share Transfer Agent. During this 6-day window, the company received NIL requests for re-lodgement of transfer of physical shares, processed NIL, approved NIL, and rejected NIL. No requests were handled during the period, and average processing time is reported as NA. This is filed pursuant to SEBI Circular dated 2 July 2025 and is a NIL status update.
This is a routine administrative/compliance filing with no material impact on shareholders or the stock price. No transfer activity took place during the reported period, and no corporate action or financial event is involved.